Folic acid supplementation reverses age-related reductions in cutaneous vasodilatation during passive heating. However, it is unknown if folic acid supplementation alleviates thermoregulatory and cardiovascular strain experienced by older adults during heat exposure. We evaluated the effect of folic acid supplementation on thermoregulatory and cardiovascular responses of nine healthy older adults (61-72 years, 3 males/6 females) exposed to extreme heat and humidity.
INTRODUCTION
It is well established that older adults are at greater risk of morbidity and mortality during heat waves (Kovats & Hajat, 2008) . A number of studies have examined age-related differences in thermoregulatory and cardiovascular responses during heat exposure as potential underlying causes for this increased risk (Kenney & Munce, 2003; Kenney, Craighead, & Alexander, 2014) . In contrast, few studies have examined potential interventions to alleviate thermoregulatory and cardiovascular strain of older adults during heat exposure. We recently evaluated the effect of electric fan use on cardiovascular and thermoregulatory responses of healthy older adults exposed to extreme heat and humidity Gagnon, Romero, Cramer, Jay, & Crandall, 2016) . Since rates of heat exchange are proportional to air velocity, fan use elevates both dry and evaporative heat exchange between the body and the environment (Jay, Cramer, Ravanelli, & Hodder, 2015; Ravanelli, Gagnon, Hodder, Havenith, & Jay, 2017) . In young adults, fan use during extreme heat exposure (42 • C) allows for additional sweat evaporation that outweighs a greater rate of dry heat gain, thus leading to an improved Experimental Physiology. 2018;103:1123-1131.
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New Findings
• What is the central question of this study?
Does folic acid supplementation alleviate thermoregulatory and cardiovascular strain of older adults during exposure to extreme heat and humidity?
• What is the main finding and its importance?
Folic acid supplementation for 6 weeks did not affect whole-limb blood flow/vasodilatation, core and skin temperatures, heart rate, blood pressure and cardiac output. Thus, 6 weeks of folic acid supplementation does not alleviate thermoregulatory or cardiovascular strain of healthy older adults exposed to extreme heat and humidity.
net heat loss and reduced thermoregulatory and cardiovascular strain (Ravanelli, Hodder, Havenith, & Jay, 2015) . However, fan use during extreme heat exposure exacerbates thermoregulatory and cardiovascular strain in older adults (Gagnon et al., 2016) . The negative effect of fan use in older adults is likely related to a diminished sweating capacity, such that a greater rate of dry heat gain with fan use is not compensated for by additional sweat evaporation . As such, alternative interventions are needed to alleviate thermoregulatory and cardiovascular strain of older adults during extreme heat exposure.
Studies employing whole-body direct calorimetry have demonstrated that older adults store more heat during simulated heat wave conditions relative to young adults (Kenny et al., 2016; Stapleton et al., 2014) . Interestingly, greater heat storage in older adults was mediated solely through greater dry heat gain in these studies as sweat evaporation was similar to young adults. These results suggest that reducing dry heat gain from the environment may represent an alternative approach to alleviate thermoregulatory and cardiovascular strain of older adults during heat exposure. As dry heat exchange is driven by the skin-to-air temperature gradient, an increase in skin temperature could be targeted as a means to minimize dry heat gain from the environment. This could be achieved by interventions that increase cutaneous blood flow. Such interventions might be particularly effective in older adults who exhibit compromised cutaneous vasodilatation during heat exposure, largely due to agerelated reductions in nitric oxide availability (Holowatz & Kenney, 2010; Kenney, 2017) . In fact, interventions that improve nitric oxide availability restore cutaneous vasodilatation of older adults to levels seen in young adults (Stanhewicz, Alexander, & Kenney, 2013 Stanhewicz, Bruning, Smith, Kenney, & Holowatz, 2012; Stanhewicz, Greaney, Alexander, & Kenney, 2017) . One such intervention is folic acid supplementation. Recent work has demonstrated that 6 weeks of high dose (5 mg day −1 ) folic acid supplementation augments cutaneous vasodilatation in older adults, restoring it to levels observed in young adults during passive heat exposure Stanhewicz, Alexander, & Kenney, 2015) . Importantly, these studies were performed under encapsulated conditions (i.e.
water-perfused suit), which did not allow for augmented cutaneous vasodilatation to provide a benefit (if any) to dry heat exchange and thermoregulatory control. Therefore, it remains unknown if greater cutaneous vasodilatation following folic acid supplementation sufficiently increases cutaneous blood flow in older adults to reduce the skin-to-air temperature gradient, thereby minimizing dry heat gain during environmental heat exposure.
The purpose of this study was to evaluate the effects of folic acid supplementation on thermoregulatory and cardiovascular responses of healthy older adults exposed to extreme heat and humidity. We tested the hypothesis that 6 weeks of folic acid supplementation (5 mg daily) would lead to greater cutaneous vasodilatation during extreme heat exposure in older adults, thus reducing the (negative)
skin-to-air temperature gradient and minimizing dry heat gain from the environment. We also hypothesized that the net effect of improved cutaneous vasodilatation would be reduced thermoregulatory (core temperature) and cardiovascular (heart rate) strain. 
METHODS

Ethical approval
Participants
Nine older, healthy adults participated in this study (68 ± 3 years, range: 61-72 years; 3 males/6 females). The data were collected as part of a larger study examining the effect of fan use in young and older adults during exposure to extreme heat and humidity.
The results of the control condition presented herein have been published previously (Gagnon et al., 2016; , but relevant data are included to specifically evaluate the effect of folic acid supplementation. Participants were non-smokers, free of known cardiovascular, respiratory, neurological or metabolic diseases and were not taking any related medications. Health status was determined by having the participants fill out a detailed medical history questionnaire, measuring their resting blood pressure and heart rate, performing a 12-lead electrocardiogram and obtaining a fasting blood sample. Study visits were performed at the same time of day. For each visit, participants were asked to arrive at the laboratory after a 12 h fast, to refrain from strenuous physical activity for 24 h, and to refrain from caffeine and alcohol for 12 h.
Protocol
Upon arrival to the laboratory, participants provided a urine sample before weighing themselves nude. They then changed into standardized shorts (males) or shorts and a sports bra (females) and sat, semi-reclined, within a room maintained at ∼24 Following an initial instrumentation period within the environmental chamber (∼10 min), the experimental protocol began with a 30 min baseline period. Relative humidity was subsequently increased by 2% every 5 min until a relative humidity of 70% (total time of 100 min, excluding initial baseline period). At the end of the protocol, a final blood sample was drawn following which air temperature was decreased to 30.9 ± 1.2 • C. Participants remained in the chamber for an additional 59 ± 3 min during which maximal cutaneous blood flow was measured by setting a local heater housing a laser-Doppler probe to 44 • C. Participants subsequently exited the chamber and weighed themselves nude. The order in which the protocol was performed was not randomized. Participants first performed the protocol under a control condition (i.e. no supplementation). They were subsequently asked to consume 5 mg of folic acid daily for 6 weeks. Participants returned to the laboratory the day after the last dose of folic acid was ingested to repeat the experimental protocol.
Measurements
Heart rate was obtained from an electrocardiogram (GE Healthcare, Milwaukee, WI, USA). to demodulation of forward and reverse Doppler frequencies (Buck, Sieck, & Halliwill, 2014) , as previously performed in our laboratory Romero et al., 2017) . Longitudinal B-mode images of the brachial artery were used to measure diameter at end-diastole using on-screen callipers. Nude body mass was measured using a scale accurate to 0. (Dill & Costill, 1974) .
Data analysis
Continuously measured data were collected with acquisition hardware (Biopac, Santa Barbara, CA, USA) at a minimum sampling frequency of and expressed as an absolute value (ml min −1 mmHg −1 ). The critical humidity at which elevations in heart rate and oesophageal temperature occurred was determined using segmented regression analysis (Gagnon et al., 2016 Ravanelli et al., 2015) . Dry heat exchange (W m −2 ) was calculated as the sum of convective and radiant heat exchanges which were estimated using partitional calorimetry, as previously described (Ravanelli et al., 2017 ).
Statistical analysis
Data were analysed using a two-way repeated measures analysis of variance with the factors of condition (control and folic acid) and relative humidity. When a condition by humidity interaction was observed, post hoc analyses were performed with a HolmSidak correction. Single time point comparisons were analysed using Student's t test for paired samples. Statistical significance was set at P < 0.05. Analyses were performed using commercially available software (Prism 7, GraphPad Software Inc., La Jolla, CA, USA). All variables are reported as mean ± 95% confidence intervals, except for participant characteristics, which are presented as mean ± standard deviation.
RESULTS
Participant characteristics
Upon arrival to the laboratory, urine specific gravity (control:
1.016 ± 0.003 vs. folic: 1.015 ± 0.004, P = 0.39) and nude body weight (control: 71.7 ± 13.1 kg vs. folic: 72.1 ± 13.0 kg, P = 0.37) did not differ between conditions.
Haematological parameters
Serum folate concentrations were greater at baseline following folic acid supplementation (360 ± 454 ng ml −1 vs. control: 14 ± 3 ng ml −1 , P < 0.01) and remained greater at the end of the experimental protocol (262 ± 217 ng ml −1 vs. control: 14 ± 2 ng ml −1 , P < 0.01).
It should be noted that for one participant, supplementation resulted in serum folate concentrations ∼15-fold greater than the mean of the other participants (control baseline: 17.7 ng ml −1 , folic acid baseline: 2202 ng ml −1 , folic acid at end of protocol: 1062 ng ml −1 ). Serum folate concentrations are nonetheless greater following supplementation if data from this participant are removed (baseline: 130 ± 51 ng ml −1 vs.
control: 14 ± 3 ng ml −1 , P < 0.01; end of protocol: 148 ± 55 ng ml −1 vs. control: 14 ± 2 ng ml −1 , P < 0.01). No condition by humidity interactions were observed for the change in plasma volume (P = 0.63) or plasma osmolality (P = 0.70, Table 1 ).
Thermoregulatory responses
A condition by humidity interaction was observed for cutaneous blood flow and cutaneous vascular conductance (both P < 0.01).
Values for cutaneous blood flow and cutaneous vascular conductance
were approximately 25% and 30% greater, respectively, throughout the protocol following folic acid supplementation (Figure 1 ). When expressed as a percentage of maximum values, a condition by humidity interaction was observed for cutaneous vascular conductance (P = 0.01), but not cutaneous blood flow (P = 0.29, Figure 2 ). Maximum cutaneous blood flow and cutaneous vascular conductance were greater (both P = 0.04) following folic acid supplementation (Figure 3 ).
In contrast, forearm blood flow (P = 0.93) and forearm vascular conductance (P = 0.95) were similar between conditions throughout the protocol (Figure 4 ). Folic acid supplementation did not affect mean skin (P = 0.81) or oesophageal (P = 0.98) temperatures ( Figure 5 ).
There were also no differences between conditions in local sweat rate (P = 0.99, Table 1 ) and whole-body sweat loss (control: 0.8 ± 0.2 kg vs.
folic acid: 0.7 ± 0.3 kg, P = 0.37). The mean skin-to-air temperature gradient became progressively less as relative humidity increased, although no differences were observed between conditions (P = 0.72, Figure 6 ). Consequently, dry heat exchange was similar between conditions (P = 0.68, Figure 6 ). The critical humidity inflection point for oesophageal temperature was similar between conditions, whether it was expressed as relative humidity (control: 63 ± 2% vs. folic acid:
60 ± 3%, P = 0.15) or water vapour pressure (control: 5.18 ± 0.14 kPa vs. folic acid: 4.94 ± 0.27 kPa, P = 0.09).
Cardiovascular responses
No condition by humidity interactions were observed for mean arterial pressure (P = 0.71), heart rate (P = 0.64), cardiac output (P = 0.20), stroke volume (P = 0.33) or systemic vascular resistance (P = 0.25, Table 1 ). The critical humidity inflection point for heart rate was unaffected by folic acid supplementation, whether it was expressed as relative humidity (control: 56 ± 3% vs. folic acid: 57 ± 5%, P = 0.61) or water vapour pressure (control: 4.61 ± 0.27 kPa vs. folic acid:
4.70 ± 0.27 kPa, P = 0.66).
DISCUSSION
This study evaluated the hypothesis that folic acid supplementation in healthy older adults results in greater cutaneous vasodilatation that would in turn lead to greater cutaneous blood flow, a higher mean skin temperature, a reduced mean skin-to-air temperature gradient, and thus diminished dry heat gain from the surrounding environment during exposure to extreme heat and humidity. While greater levels of absolute local cutaneous blood flow and vasodilatation were observed with folic acid supplementation, these differences were minimized when expressed as a percentage of maximum elicited by local heating. Furthermore, whole-limb forearm blood flow and vascular conductance, mean skin temperature, the mean skin-to-air temperature gradient and rate of dry heat exchange were unaffected.
Consequently, folic acid supplementation did not alter the observed rise in oesophageal temperature or heart rate, nor the critical humidity inflection point for either of these variables. Overall, this study demonstrates that 6 weeks of folic acid supplementation does not TA B L E 1 Heat loss, cardiovascular, and haematological responses of older adults exposed to extreme heat and humidity before (CON) and after (FOLIC) 6 weeks of folic acid supplementation Values are mean ± 95% confidence intervals. *P < 0.05 vs. baseline (i.e. 30% relative humidity) within a given condition. LSR, local sweat rate; MAP, mean arterial pressure; SVR, systemic vascular resistance alleviate thermoregulatory or cardiovascular strain of older adults exposed to extreme heat and humidity.
Central to the premise of this study is that folic acid supplementation results in greater cutaneous vasodilatation and blood flow. The obtained results provide arguments both for and against this possibility. Consistent with the possibility that folic acid supplementation improves cutaneous vasodilatation during heat exposure in older adults (Stanhewicz et al., 2015) , greater serum folate concentrations and greater absolute values of local forearm cutaneous blood flow and vascular conductance were observed. In contrast, no effect of folic acid supplementation was observed for whole-limb (Braverman & Schechner, 1991) .
Importantly, such variation becomes more pronounced (∼8-fold) following local heating of the forearm to a skin temperature of 40 • C (Braverman & Schechner, 1991) . It is therefore possible that the laser-Doppler probe was systemically placed on an area of the forearm with greater density of underlying microvasculature following folic acid supplementation. One argument in favour of this possibility is the greater cutaneous blood flow observed during local skin heating following folic acid supplementation (Figure 3 ). In fact, the effect of folic acid supplementation on local cutaneous blood flow/vascular conductance generally disappeared when values were expressed as a percentage of maximum (Figure 2 ). However, it could also be argued that greater cutaneous blood flow/vascular conductance during local skin heating was the result of folic acid supplementation.
Nitric oxide is responsible for a large proportion of the sustained vasodilatation induced by local skin heating (Choi, Brunt, Fujii, & Minson, 2014; Kellogg, Liu, Kosiba, & O'Donnell, 1999; Minson, Berry, & Joyner, 2001 ). Since folic acid supplementation improves nitric oxide availability , it is not unreasonable to suggest that greater cutaneous blood flow/vascular conductance during local skin heating reflects improved nitric oxide availability.
In support of this argument, local intradermal infusion of folic acid's active metabolite (5-methyltetrahydrofolate) augments the nitric oxide contribution to cutaneous vasodilatation induced by local heating in healthy older adults (Stanhewicz et al., 2015) .
Regardless of whether cutaneous vasodilatation and/or blood flow was or was not increased systemically by folic acid supplementation, the net effect was an unchanged mean skin temperature response.
Consequently, the mean skin-to-air temperature gradient and thus dry heat exchange were similar between conditions. In addition, local sweat production and whole-body sweat losses were unaffected by folic acid supplementation. It therefore follows that folic acid supplementation did not affect oesophageal temperature nor the critical humidity inflection point for the increase in oesophageal temperature. The critical humidity inflection point is an indicator of maximum heat loss potential (Kamon & Avellini, 1976 
FOLIC (C+R)
F I G U R E 6 Mean skin-to-air temperature gradient (T sk -T a , circles) and dry heat exchange (C+R, squares) of older adults exposed to extreme heat and humidity. The protocol was performed before (control, CON) and after 6 weeks of folic acid supplementation (FOLIC). Values are mean ± 95% confidence intervals & Zeman, 2002; Kenney, Mikita, Havenith, Puhl, & Crosby, 1993) .
We have previously demonstrated that, in young adults, furosemideinduced reductions in cutaneous blood flow do not affect the critical humidity inflection point for core temperature .
As such, conditions or interventions that elicit physiologically relevant reductions or increases in cutaneous blood flow have little to no effect upon maximum heat loss potential under extreme heat conditions. This may be particularly true if such conditions or interventions do not affect sweat production or evaporation. It is therefore unlikely that solely targeting cutaneous vasodilatation will alleviate thermoregulatory and/or cardiovascular strain of older adults during heat exposure.
Limitations
When evaluating the results of the current study, it is important to consider the following limitations. First, the environmental conditions employed in the current study were relatively extreme. Notably, air temperature was greater than mean skin temperature, such that we examined if increased cutaneous vasodilatation could reduce dry heat gain from the environment. It remains to be determined if interventions that improve cutaneous vasodilatation can improve dry heat loss of older adults exposed to air temperatures that are lower than mean skin temperature. Second, the order in which the control and supplementation conditions were performed was not randomized and no placebo group was included. Third, the results of the current study are specific to the dose of folic acid (5 mg daily) and length (6 weeks) of supplementation employed.
Conclusion
This study evaluated the effect of 6 weeks' folic acid supplementation (5 mg daily) on thermoregulatory and cardiovascular responses of healthy older adults exposed to extreme heat and humidity. Although folic acid supplementation augmented local absolute cutaneous blood flow, this increase was minimized when values were expressed as a percentage of maximum elicited by local heating. Furthermore, folic acid supplementation did not affect whole-limb forearm blood flow, mean skin temperature, the mean skin-to-air temperature gradient, dry heat exchange, oesophageal temperature or heart rate. Overall, the findings demonstrate that folic acid supplementation does not alleviate thermoregulatory or cardiovascular strain of older adults exposed to extreme heat and humidity.
